NCT03410615 Cisplatin + Radiotherapy vs Durvalumab + Radiotherapy Followed by Durvalumab vs Durvalumab + Radiotherapy Followed by Tremelimumab + Durvalumab in Intermediate-Risk HPV-Positive Oropharyngeal SCC Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03406078 Study to Evaluate the Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma Status COMPLETED Phase PHASE3
NCT03402841 Multicentre Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed Non gBRCAm Ovarian Cancer Patients Status COMPLETED Phase PHASE3
NCT03401385 First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01) Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03401229 Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal Polyposis Status COMPLETED Phase PHASE3
NCT03400488 A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Japanese Men Status COMPLETED Phase PHASE1
NCT03394144 Study of AZD9150 and MEDI4736 (Durvalumab) in Japanese Adult Patients With Advanced Solid Malignancies Status COMPLETED Phase PHASE1
NCT03394118 TAGRISSO (Osimertinib) in NSCLC Patients in Whom T790 Mutations Are Detected by Liquid Biopsy Status COMPLETED Phase PHASE2
NCT03387722 Assessment of Treatment Patterns of Severe Asthmatic Patients Across the Gulf Region - SevEos Study Status COMPLETED Phase N/A
NCT03387683 A Clinical Study to Investigate the Effects of Dapagliflozin on Heart Work, Heart Nutrient Uptake, and Heart Muscle Efficiency in Type 2 Diabetes Patients Status COMPLETED Phase PHASE4
NCT03384940 DS-8201a in Human Epidermal Growth Factor Receptor2 (HER2)-Expressing Colorectal Cancer (DESTINY-CRC01) Status COMPLETED Phase PHASE2
NCT03383692 Study of DS-8201a for Participants With Advanced Solid Malignant Tumors Status COMPLETED Phase PHASE1
NCT03381560 A Study to Evaluate the Symptoms Over 24 Hours in Patients With Chronic Obstructive Pulmonary Disease - LASSYC Study Status COMPLETED Phase N/A
NCT03381183 IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma Status COMPLETED Phase PHASE1
NCT03377738 Effectiveness of the Spirometry Test as a Motivational Tool for Quitting Tobacco in Primary Care Status COMPLETED Phase NA
NCT03377335 Dapagliflozin, Cardio-Metabolic Risk Factors and Type-2 Diabetes Status UNKNOWN Phase PHASE4
NCT03373045 Observational Study of Characteristics, Treatment and Outcomes With Severe Asthma in the United States (CHRONICLE) Status COMPLETED Phase N/A